PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis

Completed

Conditions studied: Chest Pain, Cardiovascular Diseases, Angina Pectoris, Coronary Artery Disease, CAD, CVD, CHD, Coronary Heart Disease

In brief

This is a prospective, multi-center study examining the clinical impact of the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay in approximately 250 evaluable subjects with no history of obstructive coronary artery disease who now present with chest pain or anginal-equivalent symptoms to a primary care physician (PCP) for evaluation.

Key facts

Study ID

NCT01594411

Run by

CardioDx

People needed

251

Starts

2012-04-01

Expected to finish

2013-02-01

Last updated by the study team

2019-01-31

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stable chest pain, typical or atypical angina or anginal equivalent
• The patient has signed the appropriate Institutional Review Board approved Informed Consent Form.

You may not qualify if…

• History of myocardial infarction
• Current Myocardial infarction (MI) or acute coronary syndrome.
• Current New York Heart Association (NYHA) class III or IV congestive heart failure symptoms.
• Any previous coronary revascularization.
• Any individuals with :
• Diabetes
• Suspected unstable angina
• Systemic infections
• Systemic inflammatory conditions
• Any individuals currently taking:
• Steroids
• Immunosuppressive agents
• Chemotherapeutic agents
• Any Major Surgery within 2 months

Where it is running

• John's Creek Primary Care — Suwanee, Georgia, United States
• The Lipid Center — Baton Rouge, Louisiana, United States
• Carolina Family Healthcare — Charlotte, North Carolina, United States
• Family Care Clinic — Bonham, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.